SCHEDULE 13G

Company

Alaunos Therapeutics, Inc.

Filed

May 10, 2006

Accession Number

0001169232-06-002305

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →